Innovative Research Award
Aasia Kalsoom · Pakistan Council of Scientific and Industrial Research · Pakistan
The Innovative Research Award is a research recognition category associated with the International Research Awards on Infectious Diseases. This article presents the supplied bibliographic profile of Aasia Kalsoom, affiliated with the Pakistan Council of Scientific and Industrial Research in Pakistan, with a stated subject area of development of new vaccines. The profile includes publication and citation indicators attributed to the researcher’s supplied Scopus author record. These metrics provide a quantitative overview of indexed scholarly output but do not, on their own, establish the novelty, quality, or clinical impact of individual research contributions. [1]
Abstract
This article outlines the available research-profile information for Aasia Kalsoom, whose stated institutional affiliation is the Pakistan Council of Scientific and Industrial Research. The supplied Scopus profile identifies eight documents, 56 citations, and an h-index of 4. The stated subject area is the development of new vaccines, a field relevant to infectious disease prevention, immunology, antigen research, and vaccine development. The article discusses the significance and limitations of these indicators in the context of research recognition. Specific publications, experimental findings, author contributions, and independently verified award decisions have not been supplied and are therefore not asserted here. [1] [2]
Keywords
Aasia Kalsoom; Innovative Research Award; Pakistan Council of Scientific and Industrial Research; Pakistan; development of new vaccines; infectious diseases; vaccine research; scientific publications; citation analysis; research impact; Scopus author profile; biomedical research.
Introduction
Vaccine development is an important component of infectious disease research. It involves the identification of protective antigens, evaluation of immune responses, assessment of safety, and investigation of strategies that can prevent or reduce the burden of infectious diseases. Research in this area can involve microbiology, immunology, molecular biology, biotechnology, clinical investigation, and public health. The translation of laboratory findings into effective vaccines requires evidence from appropriate experimental and clinical studies. [2] [3]
Research Profile
Aasia Kalsoom is associated in the supplied information with the Pakistan Council of Scientific and Industrial Research in Pakistan. The stated subject area is development of new vaccines. The Scopus author identifier provided for this profile is 57204200924. The profile can be consulted through the publisher’s author-detail page to examine indexed records and associated bibliographic information. [1]
Research Contributions
The supplied subject area places the research profile within the broad field of new vaccine development. Vaccine research can address scientific questions about pathogen biology, antigen selection, immune recognition, immunogenicity, protective efficacy, safety, and implementation. The specific contribution of an individual researcher must, however, be established from publications, project records, documented author roles, and relevant experimental or clinical evidence. [2] [3]
Publications
The supplied bibliometric information lists eight documents associated with the Scopus author identifier 57204200924. A publication-by-publication inventory has not been provided for this article. The linked Scopus author page is the appropriate starting point for verifying document titles, author lists, source titles, publication dates, citation records, and available digital object identifiers. [1]
Research Impact
The supplied profile reports 56 citations across eight documents and an h-index of 4. These indicators describe aspects of the recorded scholarly attention associated with the profile. Citation counts can help identify research outputs that have been referenced by later publications, while the h-index combines publication productivity and citation frequency into a single measure. Neither measure directly evaluates methodological quality, originality, clinical usefulness, or the accuracy of research findings. [1] [3]
Award Suitability
The Innovative Research Award is associated here with the International Research Awards on Infectious Diseases. The supplied institutional affiliation, stated vaccine-development subject area, and bibliometric profile provide contextual information that may be relevant when considering research in the infectious diseases field. The available data alone do not establish eligibility, nomination status, selection, or receipt of the award.[1]
Conclusion
Aasia Kalsoom’s supplied research profile identifies an affiliation with the Pakistan Council of Scientific and Industrial Research in Pakistan and a subject area of development of new vaccines. The provided Scopus indicators comprise eight documents, 56 citations, and an h-index of 4. These figures offer a limited quantitative description of indexed research activity. A fuller scholarly assessment would require verification of the author record, examination of individual publications, and evidence of specific contributions to vaccine or infectious diseases research. Award eligibility and recognition should be established through the official program and its documented evaluation process.[3]
External Links
References
- Elsevier. (n.d.). Scopus author details: Aasia Kalsoom, Author ID 57204200924. Scopus. Author-profile metrics and document records should be checked against the current database entry.
https://www.scopus.com/authid/detail.uri?authorId=57204200924
- Rasool, M., Malik, A., Waquar, S., Tul-Ain, Q., Jafar, T. H., Rasool, R., & Kalsoom, A. (n.d.). In-silico characterization and in-vivo validation of Albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease.
https://pubmed.ncbi.nlm.nih.gov/30123124/
- Kalsoom, A., Abidi, S. H., Marwat, S. A., Shabbir, G., Naveed, M., & Mughal, A. M. A. (n.d.). Immunopharmacological and structural design of a polyprotein-based multi-epitope vaccine against Powassan virus.
https://link.springer.com/article/10.1007/s00210-026-05519-y